157 related articles for article (PubMed ID: 21165704)
1. [LDL-cholesterol in secondary prevention: goal-attainment in patients on lipid-lowering drugs in private practice and in hospitals in Austria (ZIEL)].
Föger B; Patsch JR
Wien Klin Wochenschr; 2011 Jan; 123(1-2):21-7. PubMed ID: 21165704
[TBL] [Abstract][Full Text] [Related]
2. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
[TBL] [Abstract][Full Text] [Related]
3. [Lipid profiles and therapy status in the secondary prevention of high risk patients with cardiovascular disease and/or diabetes mellitus: the Austrian Hospital Screening Project (HSP)].
Roden M; Huber K;
Wien Klin Wochenschr; 2008; 120(17-18):558-65. PubMed ID: 18988009
[TBL] [Abstract][Full Text] [Related]
4. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.
Nag SS; Daniel GW; Bullano MF; Kamal-Bahl S; Sajjan SG; Hu H; Alexander C
J Manag Care Pharm; 2007 Oct; 13(8):652-63. PubMed ID: 17970603
[TBL] [Abstract][Full Text] [Related]
5. Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem.
Soubrier M; Zerkak D; Dougados M
J Rheumatol; 2006 Sep; 33(9):1766-9. PubMed ID: 16845709
[TBL] [Abstract][Full Text] [Related]
6. Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.
LaBresh KA; Owen P; Alteri C; Reilly S; Albright PS; Hordes AR; Shaftel PA; Noonan TE; Stoukides CA; Kaul AF
Am J Cardiol; 2000 Feb; 85(3A):23A-29A. PubMed ID: 10695704
[TBL] [Abstract][Full Text] [Related]
7. Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7.
Pedersen E; Garcia BH; Halvorsen KH; Eggen AE; Schirmer H; Waaseth M
BMC Cardiovasc Disord; 2021 Jan; 21(1):44. PubMed ID: 33478404
[TBL] [Abstract][Full Text] [Related]
8. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.
Pearson TA; Laurora I; Chu H; Kafonek S
Arch Intern Med; 2000 Feb; 160(4):459-67. PubMed ID: 10695686
[TBL] [Abstract][Full Text] [Related]
9. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
Kuznik A; Mardekian J
Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
[TBL] [Abstract][Full Text] [Related]
10. Goal attainment in patients referred to a telephone-based dyslipidemia program.
Palmieri J; Redline S; Morita R
Am J Health Syst Pharm; 2005 Aug; 62(15):1586-91. PubMed ID: 16030368
[TBL] [Abstract][Full Text] [Related]
11. Attainment of low-density lipoprotein cholesterol goals in coronary artery disease.
Kauffman AB; Olson KL; Youngblood ML; Zadvorny EB; Delate T; Merenich JA;
J Clin Lipidol; 2010; 4(3):173-80. PubMed ID: 21122649
[TBL] [Abstract][Full Text] [Related]
12. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease.
Kawecka-Jaszcz K; Jankowski P; Pajak A
Int J Cardiol; 2003 Sep; 91(1):15-23. PubMed ID: 12957725
[TBL] [Abstract][Full Text] [Related]
13. Persistent dyslipidemia in Austrian patients treated with statins for primary and secondary prevention of atherosclerotic events - Results of the DYSlipidemia International Study (DYSIS).
Drexel H; Chazelle F; Fauer C; Lautsch D; Gitt AK
Wien Klin Wochenschr; 2011 Oct; 123(19-20):611-7. PubMed ID: 21947362
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of low-density lipoprotein cholesterol goals achieved in patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid-lowering therapy: the South African Not at Goal study (SA-NAG).
Ramjeeth A; Butkow N; Raal FJ; Maholwana-Mokgatlhe M
Cardiovasc J Afr; 2008; 19(2):88-94. PubMed ID: 18516354
[TBL] [Abstract][Full Text] [Related]
15. [The role of lipid metabolism in the prevention of coronary heart disease].
Mathes P; Thiery J
Z Kardiol; 2005; 94 Suppl 3():III/43-55. PubMed ID: 16258792
[TBL] [Abstract][Full Text] [Related]
16. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.
Howard BV; Roman MJ; Devereux RB; Fleg JL; Galloway JM; Henderson JA; Howard WJ; Lee ET; Mete M; Poolaw B; Ratner RE; Russell M; Silverman A; Stylianou M; Umans JG; Wang W; Weir MR; Weissman NJ; Wilson C; Yeh F; Zhu J
JAMA; 2008 Apr; 299(14):1678-89. PubMed ID: 18398080
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study.
Yang YS; Yang BR; Kim MS; Hwang Y; Choi SH
Lipids Health Dis; 2020 Jan; 19(1):5. PubMed ID: 31926562
[TBL] [Abstract][Full Text] [Related]
18. Lipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand survey.
Sukonthasarn A; Homsanit M; Prommete B; Chotinaiwattarakul C; Piamsomboon C; Likittanasombat K
J Med Assoc Thai; 2011 Dec; 94(12):1424-34. PubMed ID: 22295727
[TBL] [Abstract][Full Text] [Related]
19. Impact of the attainment of current recommended low-density lipoprotein cholesterol goal of less than 70 mg/dl on clinical outcomes in very high-risk patients treated with drug-eluting stents.
Kim BK; Kim DW; Oh S; Yoon SJ; Park S; Jeon DW; Yang JY
Coron Artery Dis; 2010 May; 21(3):182-8. PubMed ID: 20168221
[TBL] [Abstract][Full Text] [Related]
20. Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in Switzerland.
Jaussi A; Noll G; Meier B; Darioli R
Eur J Cardiovasc Prev Rehabil; 2010 Jun; 17(3):363-72. PubMed ID: 20168234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
